Atezolizumab for PD-L1-Selected Patients with NSCLC
- PMID: 33567201
- DOI: 10.1056/NEJMc2032432
Atezolizumab for PD-L1-Selected Patients with NSCLC
Comment in
-
Atezolizumab for PD-L1-Selected Patients with NSCLC. Reply.N Engl J Med. 2021 Feb 11;384(6):584-585. doi: 10.1056/NEJMc2032432. N Engl J Med. 2021. PMID: 33567202 No abstract available.
Comment on
-
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.N Engl J Med. 2020 Oct 1;383(14):1328-1339. doi: 10.1056/NEJMoa1917346. N Engl J Med. 2020. PMID: 32997907 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials